Low Tumor Mutation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

/PRNewswire/ Biofidelity, a revolutionary genomic technology company, has developed a low-cost, simple and rapid assay for single-molecule detection of.

United kingdomLiz dowlingBarnaby balmforthWendy levinPrnewswire biofidelityClinical cancer researchBiofidelity co founderSimplified molecular profilingLocally advancedMetastatic non small cell lung cancerTargetable kinase fusionsMitogenic driver alteration detectedLow tumor mutationClinical cancer